The comparison of effectiveness of two drugs given via injection in the lower back for pain management in patients undergoing laparoscopic uterine removal surgery.
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/09/045697
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA 1 or ASA 2 patients undergoing elective total laparoscopic hysterectomy
Exclusion Criteria
�Patient refusal to participate.
�Known hypersensitivity to local
anaesthetic and opioids.
�Patient having an infection at the site of
intervention.
� Patient having spinal deformities and
previous history of spine surgery.
�Patients on anticoagulation therapy.
�Patients with untreated psychiatric
illness that would interfere with pain
perception and assessment
�Patients with history of drug or alcohol
abuse
�Patients with BMI > 30kg/m2
�Patients with symptomatic cardiac and or
respiratory disease.
�Regular use of opioids
�History of shoulder trauma or surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cumulative fentanyl consumption <br/ ><br> <br/ ><br>Timepoint: 24hours <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method �Duration of <br/ ><br> analgesia(time for the <br/ ><br> first analgesia <br/ ><br> injection in <br/ ><br> postoperative period). <br/ ><br>�11-point NRS scores at <br/ ><br> rest and at movement <br/ ><br> in postoperative <br/ ><br> period at the time <br/ ><br> interval of 2 hours, 4 <br/ ><br> hours, 6 hours,12 <br/ ><br> hours and 24 hours. <br/ ><br>�Adverse events in 24 <br/ ><br> hours <br/ ><br> <br/ ><br>�Patient satisfaction <br/ ><br> score. <br/ ><br> <br/ ><br>Timepoint: 24 hours